Banque Cantonale Vaudoise’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,000
Closed -$246K 1259
2022
Q3
$246K Hold
1,000
0.01% 664
2022
Q2
$247K Hold
1,000
0.01% 680
2022
Q1
$331K Hold
1,000
0.01% 669
2021
Q4
$359K Hold
1,000
0.01% 675
2021
Q3
$326K Sell
1,000
-140
-12% -$47.4K 0.01% 694
2021
Q2
$356K Buy
1,140
+140
+14% +$42.9K 0.02% 694
2021
Q1
$319K Sell
1,000
-100
-9% -$32K 0.02% 650
2020
Q4
$356K Sell
1,100
-1,200
-52% -$332K 0.02% 585
2020
Q3
$637K Buy
2,300
+400
+21% +$115K 0.04% 373
2020
Q2
$458K Sell
1,900
-1,200
-39% -$241K 0.03% 410
2020
Q1
$450K Buy
3,100
+2,300
+288% +$382K 0.04% 392
2019
Q4
$136K Buy
+800
New +$148K 0.01% 774

Other funds holding ABMD

Banque Cantonale Vaudoise's ABMD Position: Q4 2022 in Review

Banque Cantonale Vaudoise sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,000 shares — an estimated $246K sold.

Banque Cantonale Vaudoise first reported a position in ABMD in Q4 2019 and held it in 12 quarters. The position peaked at $637K in Q3 2020. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Banque Cantonale Vaudoise reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 1,000 Abiomed Inc shares in Q4 2022, an estimated $246K.
  • Banque Cantonale Vaudoise first reported a position in Abiomed Inc in Q4 2019 and held it in 12 quarters.
  • Banque Cantonale Vaudoise's Abiomed Inc position peaked at $637K in Q3 2020.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Banque Cantonale Vaudoise's 13F filing for Q4 2022, filed 10 Feb 2023.